Citius Pharmaceuticals (CTXR) Cash from Financing Activities (2010 - 2026)
Citius Pharmaceuticals (CTXR) reported Cash from Financing Activities of $23.09 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 101.4% from $11.47 million a year earlier.
Citius Pharmaceuticals (CTXR) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Citius Pharmaceuticals' Cash from Financing Activities came in at $58.54 million, up 325.3% year-over-year; for FY2025 (ended Sep 30, 2025), it came in at $33.3 million, up 234.0% from FY2024.
- Cash from Financing Activities has a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
- By fiscal year, Cash from Financing Activities came in at $9.97 million in FY2024 (-27.9%), $13.83 million in FY2023 and $120.47 million in FY2021 (+426.1%).
- The fiscal Q3 2026 figure ranks as the highest quarterly Cash from Financing Activities since fiscal Q2 2021.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$1.23 million (Q2 2026), $20.88 million (Q1 2026) and $15.79 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Citius Pharmaceuticals | 14.55 Mn | 23.85 Mn | 1.00 Mn | 23.09 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.09 Mn |
| Mar 31, 2026 | -1.23 Mn |
| Dec 31, 2025 | 20.88 Mn |
| Sep 30, 2025 | 15.79 Mn |
| Jun 30, 2025 | 11.47 Mn |
| Mar 31, 2025 | 3.47 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | -3.75 Mn |
| Sep 30, 2023 | -687.00 |
| Jun 30, 2023 | 13.80 Mn |
| Jun 30, 2021 | 16.80 Mn |
| Mar 31, 2021 | 103.67 Mn |
| Dec 31, 2020 | 500.00 |
| Sep 30, 2020 | 8.70 Mn |
| Jun 30, 2020 | 8.17 Mn |
| Mar 31, 2020 | 6.03 Mn |
| Dec 31, 2019 | 106.00 |
| Sep 30, 2019 | 6.29 Mn |
| Jun 30, 2019 | 4.83 Mn |
| Mar 31, 2019 | 7,216.00 |
Citius Pharmaceuticals Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CTXR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "CTXR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=CTXR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();